# Herbalife Ltd. (HLF) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Consumer Defensive / Personal Care. Price $14.38, market value $1.5 billion.

## Valuation
- **P/E (trailing): 8.5×** (5-yr avg 6.8×, 3-yr avg 6.4×). Herbalife Ltd. trades at 8.5× trailing earnings, well above its own five-year average of 6.8×: investors are paying up relative to the company's past. The Consumer Defensive median in the September 2026 study was 20.1×. Forward P/E is 4.8×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.3×**. Each dollar of revenue is priced at 0.3×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **EV / EBITDA: 5.0×**. Enterprise value is 5.0× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 22.6%** (5-yr avg 15.5%). Free cash flow equals 22.6% of the market value, above its five-year average of 15.5%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 11.8%**. The inverse of the P/E: 11.8% of the price is earned each year.

## Profitability
- **Gross margin: 77.6%**. Herbalife Ltd. keeps 77.6% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 9.6%**. 9.6% of revenue is left after running the business.
- **Net margin: 4.5%**. 4.5% of each dollar of sales reaches the bottom line.
- **Return on equity: -44.3%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 35.5%**. Return on all capital, debt included, is 35.5%: comfortably above what that capital costs.
- **Return on assets: 6.5%**. Each dollar of assets produces 6.5% of profit.

## Growth
- **Revenue growth (1 yr): 0.9%** (3-yr -1.1%/yr, 5-yr -1.9%/yr). Revenue grew 0.9% over the last year, against -1.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -12.0%** (3-yr -12.0%/yr, 5-yr -4.5%/yr). Earnings per share fell 12.0%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 8.8%/yr**. Free cash flow has compounded at 8.8% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Net debt / EBITDA: 2.6×**. It would take 2.6 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 1.13** (quick 1.13). Current assets cover the next year's liabilities 1.13 times.
- **Altman Z-score: 2.45**. A Z-score of 2.45 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Herbalife Ltd. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 66.0%** (YTD 3.0%, 3-mo 4.3%). The shares are up 66.0% over twelve months including dividends.
- **From 52-week high: -29.5%** (81.1% above the low). Trading 30% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 51**. An RSI of 51 is neutral.
- **Beta (1 yr): 1.10** (volatility 59%). Beta of 1.10 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=HLF · Page: https://foliofundamentals.com/stocks/hlf

Not investment advice.